← Insider buys
AKBA

Akebia Therapeutics, Inc. · Healthcare

SVP and Chief Business Officer Michel Dahan sold $75K of Akebia Therapeutics, Inc.

Sold$75,000
$15.00Price
5,000Shares
−5%Stake

What AKBA did after the filing

Prices for AKBA after this filing aren't in yet.

Traded Tue, Aug 15. Filed Thu, Aug 17, 12:06 PM ET, during the session. Not investment advice.